Sinovent

Small molecule drug development platform in China.

Launch date

2017

Market cap

Enterprise valuation

$1.3b (Public information from Feb 2024)

Suzhou Shi Jiangsu (HQ)

Date	Investors	Amount	Round
May 2018	Loyal Valley Capital	N/A	Series A
Aug 2020	Loyal Valley Capital	$145m	Series C
Dec 2020*	China Development Bank Capital Jiuyou Capital ABC International Holdings Fengyuan Capital Deguan Capital Oceanpine Capital	CNY200m	Late VC
Feb 2024*	Tencent Loyal Valley Capital HuaKong Equity Investment Sea of Stars Capital Guoxin Investment Zhuopu Capital Guangdong Development Capital Pudong Venture Capital Jinan Production and Development	CNY700m Valuation: CNY9.5b	Series E
Total Funding		$269m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Sinovent